EssexBio

Essex-Bio Group

简繁 EN

COMPANY NEWS

EssexBio to Participate in APAO 2026 and Showcase Key Ophthalmology Assets

2026.01.22

EssexBio Forms Strategic Cooperation with Kenvue for Motrin®, Tylenol® and Rhinocort®

2025.12.17

Essex Bio-Technology establishes strategic collaboration with Biosparc Signs MOU with SIPIPO and Biosparc on International Innovation Accelerator

2025.11.21

Date

Title

2018-02-26

Essex Bio-Technology announces investment in MeiraGTx, a biotech company developing novel gene therapy treatments

This website uses cookies to improve your overall experience. With your continued use, you are agreeing to accept our use of cookies.

ACCEPT